Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from starting treatment with agonist replacement therapies (START)

Journal of Studies on Alcohol and Drugs

Volumn 74, Issue 4, 2013, Pages 605-613

  Potter, Jennifer S ^a   Marino, Elise N ^a   Hillhouse, Maureen P ^b   Nielsen, Suzanne ^c   Wiest, Katharina ^d   Canamar, Catherine P ^e   Martin, Judith ^f   Ang, Alfonso ^b   Baker, Rachael ^d   Saxon, Andrew J ^g   Ling, Walter ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CODA Inc ^*  (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f San Francisco's Department of Public Health   (United States)

^g VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884709762     PISSN: 19371888     EISSN: 19384114     Source Type: Journal    
DOI: 10.15288/jsad.2013.74.605     Document Type: Article

References (26)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders, text revision (4th ed.). Washington, DC: Author.
2. Banta-Green, C. J., Maynard, C., Koepsell, T. D., Wells, E. A., & Donovan, D. M. (2009). Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users. Addiction, 104, 775-783.
3. Booth, R. E., Watters, J. K., & Chitwood, D. D. (1993). HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. American Journal of Public Health, 83, 1144-1148.
4. Brands, B., Blake, J., Sproule, B., Gourlay, D., & Busto, U. (2004). Prescription opioid abuse in patients presenting for methadone maintenance treatment. Drug and Alcohol Dependence, 73, 199-207.
5. Corsi, K. F., Lehman, W. K., & Booth, R. E. (2009). The effect of metha-done maintenance on positive outcomes for opiate injection drug users. Journal of Substance Abuse Treatment, 37, 120-126.
6. Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51, 253-263, discussion 267-268.
7. Darke, S., Hetherington, K., Ross, J., Lynskey, M., & Teesson, M. (2004). Non-injecting routes of administration among entrants to three treatment modalities for heroin dependence. Drug and Alcohol Review, 23, 177-183.
8. Hausman, J. A. (1978). Specification tests in econometrics. Econometrica, 46, 1251-1271.
9. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C., & Fagerström, K. O. (1991). The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, 1119-1127.
10. Hutchinson, S. J., Taylor, A., Gruer, L., Barr, C., Mills, C., & Elliott, L. (2000). One-year follow-up of opiate injectors treated with oral meta-done in a GP-centered programme. Addiction, 95, 1055-1068.
11. McLellan, A. T., Arndt, I. O., Metzger, D. S., Woody, G. E., & O'Brien, C. P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269, 1953-1959.
12. Moore, B. A., Fiellin, D. A., Barry, D. T., Sullivan, L. E., Chawarski, M. C., O'Connor, P. G., & Schottenfeld, R. S. (2007). Primary care office-based buprenorphine treatment: Comparison of heroin and prescription opioid dependent patients. Journal of General Internal Medicine, 22, 527-530.
13. Neaigus, A., Miller, M., Friedman, S. R., Hagen, D. L., Sifaneck, S. J., Ildefonso, G., & des Jarlais, D. C. (2001). Potential risk factors for the transition to injecting among non-injecting heroin users: A comparison of former injectors and never injectors. Addiction, 96, 847-860.
14. Neufeld, K., King, V., Peirce, J., Kolodner, K., Brooner, R., & Kidorf, M. (2008). A comparison of 1-year substance abuse treatment outcomes in community syringe exchange participants versus other referrals. Drug and Alcohol Dependence, 97, 122-129.
15. Nielsen, S., Hillhouse, M., Mooney, L., Fahey, J., & Ling, W. (2012). Comparing buprenorphine induction experience with heroin and prescription opioid users. Journal of Substance Abuse Treatment, 43, 285-290.
16. Peirce, J. M., Petry, N. M., Stitzer, M. L., Blaine, J., Kellogg, S., Satterfield, F., Li, R. (2006). Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: A National Drug Abuse Treatment Clinical Trials Network study. Archives of General Psychiatry, 63, 201-208.
17. Puigdollers, E., Domingo-Salvany, A., Brugal, M. T., Torrens, M., Alvarós, J., Castillo, C., Vázquez, J. M. (2004). Characteristics of heroin addicts entering methadone maintenance treatment: Quality of life and gender. Substance Use & Misuse, 39, 1353-1368.
18. Rosenblum, A., Parrino, M., Schnoll, S. H., Fong, C., Maxwell, C., Cle-land, C. M., Haddox, J. D. (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence, 90, 64-71.
19. Saxon, A. J., Ling, W., Hillhouse, M., Thomas, C., Hasson, A., Ang, A., Jacobs, P. (2013). Buprenorphine/naloxone and methadone effects on laboratory indices of liver health: A randomized trial. Drug and Alcohol Dependence, 128, 71-76.
20. Small, K. A., & Hsiao, C. (1985). Multinomial logit specification tests. International Economic Review, 26, 619-627.
21. Strain, E. C., Bigelow, G. E., Liebson, I. A., & Stitzer, M. L. (1999). Moderate vs high-dose methadone in the treatment of opioid dependence: A randomized trial. Journal of the American Medical Association, 281, 1000-1005.
22. Ware, J. E., Jr., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36): I. Conceptual framework and item selection. Medical Care, 30, 473-483.
23. Weiss, R. D., Potter, J. S., Fiellin, D. A., Byrne, M., Connery, H. S., Dickinson, W., Ling, W. (2011). Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: A 2-phase randomized controlled trial. Archives of General Psychiatry, 68, 1238-1246.
24. World Health Organization. (1997). Composite International Diagnostic Interview - Version 2.1. Geneva, Switzerland: Author.
25. Wu, L. T., Woody, G. E., Yang, C., & Blazer, D. G. (2011). How do prescription opioid users differ from users of heroin or other drugs in psycho-pathology: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Addiction Medicine, 5, 28-35.
26. Young, A. M., & Havens, J. R. (2012). Transition from first illicit drug use to first injection drug use among rural Appalachian drug users: A cross-sectional comparison and retrospective survival analysis. Addiction, 107, 587-596.